Summary
Overview
Work History
Education
Skills
SELECTED HIGHLIGHTS
Timeline
Generic

MANU SATYAVOLU

Palo Alto,USA

Summary

Venture Partner with over 5 years of experience in biotech venture capital, clinical data management, and translational research. Proven track record in sourcing deals, conducting scientific and financial due diligence, and building founder relationships in health tech and diagnostics. Passionate about investing in transformative technologies that improve patient outcomes. Skilled at cross-functional communication between scientists, investors, and physicians. Currently, I am helping to lead fundraising and investment strategy at a fast-growing, early-stage VC fund. Skilled in fostering strong client relationships and providing innovative solutions for complex problems. Showcased ability to drive success through operational efficiencies and process improvements.

Overview

5
5
years of professional experience

Work History

Venture Partner

Arben Ventures
Palo Alto, CA
04.2024 - Current
  • Early-stage venture fund investing in biotech and healthtech startups (70+ investments to date).
  • Spearhead founder meetings and diligence calls—assessing product-market fit, scientific rigor, competitive landscape, and regulatory pathways.
  • Independently sourced and vetted 10+ high-potential startups across diagnostics, AI-driven drug discovery, and digital health.
  • Collaborate closely with General Partners to present investment theses and shape portfolio strategy.
  • Raised over $100K+ by engaging LPs and institutional investors as part of Arben’s new $25M fundraise.
  • Track industry trends and build strategic relationships to bring differentiated deal flow into the pipeline.

Clinical Data Manager, Bone Marrow Transplant Program

Stanford University School of Medicine
Palo Alto, CA
01.2022 - Current
  • Manage clinical data for 3,000+ patient records, ensuring compliance with CIBMTR standards and supporting multi-site research trials.
  • Built automated data workflows that improved reporting accuracy by 20% and cut audit time in half.
  • Partner with hematology/oncology physicians to evaluate new therapeutic options and propose trials with the greatest remission potential.
  • Successfully identified and pitched new biotech treatments, influencing trial selection and patient stratification strategy.

Research Associate, Molecular Biology & Translational Science

Genentech Inc.
San Francisco, CA
04.2021 - 01.2022
  • Conducted DNA/RNA isolation and processing across 5+ tissue types in support of precision medicine initiatives.
  • Developed a sample management protocol that cut turnaround times by 45% for downstream sequencing studies.
  • Collaborated with international sites and led project-level communication with cross-disciplinary stakeholders.
  • Contributed to early-stage exploratory partnerships across Europe and Australia.

Quality Control Associate

Lucira Health Inc.
San Francisco, CA
06.2020 - 04.2021
  • Played a key role in validating and launching Lucira’s FDA-authorized at-home COVID-19 test (94% accuracy).
  • Led QC testing across 3 production lines and created SOPs adopted across the QA team.
  • Helped optimize supply chain workflows, reducing vendor turnaround time by 30%.
  • Analyzed test reliability data using MATLAB and Excel, influencing updates to design specs.

Education

M.S. - Biomedical Sciences

Southern California University of Health Sciences
Los Angeles, CA
12.2022

B.S. - Biology

University of California, Riverside
Riverside, CA
06.2020

Skills

  • Venture Capital Fundraising Due Diligence Startup Evaluation
  • Biotech and healthtech Diagnostics Femtech Longevity
  • Market Research Financial analysis Regulatory Strategy
  • Clinical Data Management Oncology Study Design
  • Tools: Epic R Studio FormsNet MATLAB Excel PowerPoint

SELECTED HIGHLIGHTS

  • Raised six figures in LP capital for VC fund expansion
  • Vetted and sourced investments across AI, diagnostics, oncology, and digital health
  • Improved clinical data accuracy and audit efficiency at Stanford by 20–50%
  • Supported FDA clearance of an at-home COVID-19 test during the pandemic
  • Worked across academia, big pharma, startups, and VC—bridging science and strategy

Timeline

Venture Partner

Arben Ventures
04.2024 - Current

Clinical Data Manager, Bone Marrow Transplant Program

Stanford University School of Medicine
01.2022 - Current

Research Associate, Molecular Biology & Translational Science

Genentech Inc.
04.2021 - 01.2022

Quality Control Associate

Lucira Health Inc.
06.2020 - 04.2021

M.S. - Biomedical Sciences

Southern California University of Health Sciences

B.S. - Biology

University of California, Riverside
MANU SATYAVOLU